Synchronization of posttranslational modifications during aging

There is an urgent need for surrogate biomarkers in clinical diagnostics but also preclinical in toxicology of chemicals and efficacy testing of pharmaceuticals. On the background of the emerging fields of systems biology and theranostics, the importance of time scales and the synchronization of complex biological readouts become increasingly obvious. Systemic effects such as responses to stimuli, medical intervention, cellular stress, or toxicity elicit immediate molecular changes on the protein level. Early events include phosphorylation and oxidation of proteins. These posttranslational modifications have a direct impact on enzyme activities and protein–protein interactions. Only at downstream stages is gene transcription activated. Here we outline the analytical and statistical requirements dealing with complex patterns of protein expression and the extraction of protein surrogate biomarkers defining specific early stages of biological responses. We also present successful examples from research on aging and discuss prerequisites and necessary considerations while moving candidates to validation.

[1]  Jocelyn Kaiser,et al.  Proteomics. Public-private group maps out initiatives. , 2002, Science.

[2]  Rolf Apweiler,et al.  The Proteomics Standards Initiative , 2003, Proteomics.

[3]  Chris F. Taylor,et al.  Guidelines for reporting the use of mass spectrometry informatics in proteomics , 2008, Nature Biotechnology.

[4]  K. Groebe,et al.  Nonenzymatic posttranslational protein modifications in ageing , 2008, Experimental Gerontology.

[5]  A. Ivens,et al.  A software framework for microarray and gene expression object model (MAGE-OM) array design annotation , 2008, BMC Genomics.

[6]  Hong Wang,et al.  Proteomic global profiling for cancer biomarker discovery. , 2009, Methods in molecular biology.

[7]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[8]  Norman W. Paton,et al.  An analysis of extensible modelling for functional genomics data , 2005, BMC Bioinformatics.

[9]  Lennart Martens,et al.  The minimum information about a proteomics experiment (MIAPE) , 2007, Nature Biotechnology.

[10]  Chris F. Taylor,et al.  Guidelines for reporting the use of gel electrophoresis in proteomics , 2008, Nature Biotechnology.

[11]  André Schrattenholz,et al.  A connection between the mitochondrial permeability transition pore, autophagy, and cerebral amyloidogenesis. , 2008, Journal of proteome research.

[12]  Christine Hoogland,et al.  MIAPEGelDB, a web-based submission tool and public repository for MIAPE gel electrophoresis documents. , 2008, Journal of proteomics.

[13]  Paul Landais,et al.  Evaluation and validation of diagnostic tests for guiding therapeutic decisions. , 2009, Therapie.

[14]  André Schrattenholz,et al.  Neuronal cell culture from human embryonic stem cells as in vitro model for neuroprotection. , 2007, ALTEX.

[15]  J. V. Van Eyk,et al.  Biomarker discovery: proteome fractionation and separation in biological samples. , 2008, Physiological genomics.

[16]  John J Lemasters,et al.  Role of mitochondrial permeability transition pores in mitochondrial autophagy. , 2004, The international journal of biochemistry & cell biology.

[17]  André Schrattenholz,et al.  What does systems biology mean for drug development? , 2008, Current medicinal chemistry.

[18]  Hiroaki Kitano,et al.  Next generation simulation tools: the Systems Biology Workbench and BioSPICE integration. , 2003, Omics : a journal of integrative biology.

[19]  Hiroaki Kitano,et al.  The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..

[20]  Lennart Martens,et al.  PRIDE: a public repository of protein and peptide identifications for the proteomics community , 2005, Nucleic Acids Res..

[21]  Colin L. Masters,et al.  Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.

[22]  Lennart Martens,et al.  PRIDE: new developments and new datasets , 2007, Nucleic Acids Res..

[23]  G. Schwall,et al.  Comparative profiling of the mammalian mitochondrial proteome: multiple aconitase-2 isoforms including N-formylkynurenine modifications as part of a protein biomarker signature for reactive oxidative species. , 2006, Journal of proteome research.

[24]  André Schrattenholz,et al.  Comparison of different separation technologies for proteome analyses: isoform resolution as a prerequisite for the definition of protein biomarkers on the level of posttranslational modifications. , 2006, Journal of chromatography. A.

[25]  L. Hood,et al.  Systems medicine: the future of medical genomics and healthcare , 2009, Genome Medicine.

[26]  L. Stefanis Caspase-Dependent and -Independent Neuronal Death: Two Distinct Pathways to Neuronal Injury , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[27]  Caroline Dive,et al.  Quantitative mass spectrometry-based techniques for clinical use: Biomarker identification and quantification , 2008, Journal of Chromatography B.

[28]  Sergio Contrino,et al.  The ArrayExpress gene expression database: a software engineering and implementation perspective , 2005, Bioinform..

[29]  G. Schwall,et al.  Molecular analysis of homocysteic acid-induced neuronal stress. , 2004, Journal of proteome research.

[30]  H. Klocker,et al.  Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: Cancer association of annexin A3 , 2007, Proteomics.

[31]  Susumu Goto,et al.  The KEGG resource for deciphering the genome , 2004, Nucleic Acids Res..

[32]  Antje Chang,et al.  BRENDA, enzyme data and metabolic information , 2002, Nucleic Acids Res..

[33]  C. Oliveira,et al.  Mitochondrial Dysfunction and Reactive Oxygen Species in Excitotoxicity and Apoptosis: Implications for the Pathogenesis of Neurodegenerative Diseases , 2003, Neurochemical Research.

[34]  André Schrattenholz,et al.  What does it need to be a biomarker? Relationships between resolution, differential quantification and statistical validation of protein surrogate biomarkers , 2007, Electrophoresis.

[35]  Heinz D. Osiewacz,et al.  Differential proteomic profiling of mitochondria from Podospora anserina, rat and human reveals distinct patterns of age-related oxidative changes , 2007, Experimental Gerontology.

[36]  D. Nicholls Mitochondrial calcium function and dysfunction in the central nervous system. , 2009, Biochimica et biophysica acta.